COVID vaccine for children less effective against Omicron, but booster helps, study finds
CBSN
The protection offered by two doses of Pfizer's COVID-19 vaccine in children declined during the Omicron wave, but a booster shot helped, suggests a new report published by the Centers for Disease Control and Prevention examining data from health care facilities across 10 states.
The study's authors chalked up much of the drop in protection to the Omicron variant. The effectiveness of two Pfizer shots in curbing the risk of E.R. or urgent care visits with COVID-19 declined to 46% among children ages 5 to 11; 45% among 12- to 15-year-olds, and 34% among 16- and 17-year-olds during the wave.
Vaccine effectiveness was lowest among children 12 and older who were vaccinated at least five months earlier but had not received a booster shot; for them, the study found "no significant protection" during Omicron. But protection for children with a third dose was 81% during Omicron.
Measles is still making headlines in 2025, prompting questions about the life-threatening disease and how to prevent it.
It is common among older adults to not consistently get a full night's rest. But there are ways to improve sleep issues.
Microsoft is pulling the plug on Skype, the pioneering Internet telecommunications and video call platform it bought nearly 14 years ago for $8.5 billion.
Measles cases popping up across the United States, including an outbreak in Texas that has led to the death of a child, are prompting questions about where exactly the illness has been detected.